Edition:
India

Adamis Pharmaceuticals Corp (ADMP.OQ)

ADMP.OQ on NASDAQ Stock Exchange Capital Market

4.15USD
22 Jan 2018
Change (% chg)

$-0.20 (-4.60%)
Prev Close
$4.35
Open
$4.35
Day's High
$4.35
Day's Low
$4.15
Volume
25,614
Avg. Vol
89,279
52-wk High
$6.45
52-wk Low
$3.00

Latest Key Developments (Source: Significant Developments)

Adamis Pharmaceuticals Announces Submission Of Investigational New Drug (Ind) Application To The FDA
Tuesday, 5 Dec 2017 

Dec 4 (Reuters) - Adamis Pharmaceuticals Corp ::ADAMIS PHARMACEUTICALS ANNOUNCES SUBMISSION OF INVESTIGATIONAL NEW DRUG (IND) APPLICATION TO THE FDA FOR NEW PRODUCT CANDIDATE FOR THE TREATMENT OF OPIOID OVERDOSE.  Full Article

Adamis Pharma Submits Prior Approval Supplement To FDA For The Pediatric Version Of Symjepi
Thursday, 30 Nov 2017 

Nov 29 (Reuters) - Adamis Pharmaceuticals Corp ::ADAMIS PHARMACEUTICALS SUBMITS PRIOR APPROVAL SUPPLEMENT TO FDA FOR THE PEDIATRIC VERSION OF SYMJEPI.ADAMIS PHARMACEUTICALS CORP - SUBMISSION OF A PRIOR APPROVAL SUPPLEMENT TO U.S. FOOD AND DRUG ADMINISTRATION FOR PEDIATRIC VERSION (0.15MG) OF SYMJEPI.  Full Article

Sabby Management, LLC reports 7.73 pct passive stake in Adamis Pharmaceuticals
Wednesday, 10 Aug 2016 

Adamis Pharmaceuticals Corp : Sabby Management, LLC reports 7.73 pct passive stake in Adamis Pharmaceuticals as of August 3, 2016 - SEC Filing Source - http://bit.ly/2aJYpKi Further company coverage: [ADMP.O] ((Bangalore.newsroom@thomsonreuters.com;)).  Full Article

CVI Investments reports 5.5 pct passive stake in Adamis Pharmaceuticals
Monday, 8 Aug 2016 

:CVI Investments Inc reports a passive stake of 5.5 percent in Adamis Pharmaceuticals Corp as of July 29, 2016 - SEC Filing.  Full Article

Adamis Pharmaceuticals announces $11.1 mln offering
Friday, 29 Jul 2016 

Adamis Pharmaceuticals Corp : Adamis Pharmaceuticals announces $11.1 million registered direct offering . Estimates that net offering proceeds, after deducting placement agent fees, will be approximately $10.3 million .Adamis Pharmaceuticals Corp says offering was priced at $3.095 per unit.  Full Article

Adamis Pharmaceuticals- private placement of about $5 mln
Tuesday, 12 Jul 2016 

Adamis Pharmaceuticals Corp : Adamis Pharmaceuticals announces private placement . Says received gross cash proceeds of approximately $5 million .Says issued 1.7 million shares of series A-2 convertible preferred stock to a small number of institutional investors.  Full Article

Adamis receives response letter from FDA for its epinephrine syringe
Monday, 6 Jun 2016 

Adamis Pharmaceuticals : FDA indicated that in order to support approval of product, company must expand its human factors study . Believes that it can finalize study protocols with FDA and complete additional testing within a "relatively short period of time" . Believes that it can submit data back to FDA sometime in second half of 2016 .Receives complete response letter from FDA for its epinephrine pre-filled syringe NDA.  Full Article

Adamis Pharmaceuticals Completes Acquisition of US Compounding
Tuesday, 12 Apr 2016 

Adamis Pharmaceuticals Corporation:completed its previously announced acquisition (the "Acquisition") of US Compounding, Inc. ("USC").Upon the closing of this transaction, USC has become a wholly-owned subsidiary of Adamis.  Full Article

BRIEF-Adamis Pharmaceuticals Subsidiary Develops Compound To Manage Ulcers In Horses

* US COMPOUNDING, A SUBSIDIARY OF ADAMIS PHARMACEUTICALS, DEVELOPS A UNIQUE COMPOUND TO MANAGE ULCERS IN HORSES Source text for Eikon: Further company coverage: